David J. Chang serves as Chief Medical Officer at Cabaletta Bio, Inc., where they oversee executive responsibilities. Since joining the company, David J. Chang has executed 1 insider transactions totaling $19.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 21, 2026 involved purchasing 8,800 shares valued at $19.9K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 21, 2026 | CABA | $19.9K | Purchase | 8,800 | $2.26 | Discretionary |
David J. Chang currently holds 8,800 shares of Cabaletta Bio, Inc. (CABA), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, David J. Chang has been a net buyer of CABA stock. They have purchased $19.9K and sold $0 worth of shares.
David J. Chang's most recent insider trade was on Jan 21, 2026, when they purchased 8,800 shares at $2.26 per share.
Get notified when new Form 4 filings are submitted